Veteran healthcare industry executive Vern Davenport is signing on in dual roles at Medfusion, which recently was reacquired from Intuit by its founder Steve Malik. Davenport will serve as president and also is now an equity partner in the privately held healthcare technology business.

Malik will remain Medfusion’s chief executive officer.

Davenport’s appointment is being announced Tuesday.

The two executives have known each other for several years. Medfusion was a partner with Misys Healthcare when Davenport ran that business.

“We are pleased to have a healthcare IT expert like Vern join our organization as an equity partner and member of our executive team,” said Malik, who also is Medfusion’s board chairman. “Utilizing technology to bring innovation to the changing healthcare market is the ultimate goal at Medfusion and our growing team is now even better positioned to build on the wealth of talent centralized in North Carolina.”

Davenport also is a member of the Medfusion board.

Terms of his investment as an equity partner were not disclosed. 

Last month, Vikram Natrajan, a former tech leader Medfusion from 2003 to 2008, rejoined the company  as its chief technology officer as Malik reboots Medfusion three years after he sold it Intuit for $91 million.

Medfusion, which Malik founded in 1996, developed software tools to help doctors communicate with patients. Those tools covered a range of services including online billing, prescription refills, appointments and lab results, all through an online portal.

Malik reacquired the company, which had changed its name to Intuit Health, in August. In October, Malik changed the name back to Medfusion.

Davenport, a native of North Carolina, is a graduate of East Carolina University where he received undergraduate degree in business as well as an MBA. He most recently worked at Mediquest. 

At Misys Healthcare, Davenport coordinated the firm’s merger with Allscripts. He also has worked at Kodak Health, Siemens Medical, and IBM. 

“I am confident that my experience combined with Steve’s product knowledge, exceptional talent for strategy and distinctive vision will offer us the opportunity to enhance our technology to better serve the needs of our current and perspective clients,” Davenport said. “Medfusion has a long-standing tradition of providing the market with the best solutions possible that meet the needs of the market before there is a groundswell behind it. I am excited to help the organization as we move forward with developing cutting-edge technology.”